Denali Therapeutics
DNLI
#3955
Rank
A$3.55 B
Marketcap
$24.51
Share price
1.23%
Change (1 day)
6.86%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2023 (TTM): -$1.56

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.64. In 2022 the company made an earnings per share (EPS) of -$4.06 a decrease over its 2021 EPS that were of -$3.74.

EPS history for Denali Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.56-61.65%
2022-$4.068.79%
2021-$3.74-712.82%
2020$0.61-118.93%
2019-$3.22402.44%
2018-$0.64-88.89%
2017-$5.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.91 77.14% Jersey
-$11.24 584.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.22 96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.69 490.48%๐Ÿ‡ฌ๐Ÿ‡ง UK